- The hospital profitability divide: 10 things to know
- A rural hospital is building AI with an NP leading the way
- Iowa dentist disciplined for unsanitary practice conditions
- ADA honors 10 new dentists for excellence in field
- Orthodontist pay vs. cost of living by state
- Oral surgeon pay vs. cost of living by state
- Wildfire smoke strafes Midwest, Northeast: 6 things healthcare leaders should know
- 9 pharmacy groups warn revised ACIP charter could delay vaccine access: 6 notes
- Private equity’s legal playbook for physician practices
- The outpatient orthopedic model built around doing less
- Where ASCs can find cost savings after the easy wins are gone
- NYU Langone grows South Florida presence with 2 practices
- The hidden cost of the GLP-1 boom: 5 notes
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- Montefiore leader joins Northwell hospital as CNO, VP of patient care services
- Bad debt, charity care surge continues to squeeze hospitals
- 3 cardiology societies urge CMS to update TAVR coverage rules: 5 priorities
- UCSF nurses, physicians protest ED ‘boarding crisis’
- Missouri outlaws insurance time limits on anesthesia: 5 things to know
- Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy
- Why ASCs should be watching the Medicare Advantage exodus
- LightForce Orthodontics appoints new CEO
- 39 behavioral health executive moves to know
- Good news for anesthesia
- MAX Surgical Specialty Management selects Sensei Cloud as enterprise practice management system
- Why some ASCs ‘are going to be left out’ of healthcare’s next era
- Median pay for anesthesiologists reaches $391K: Breakdown by state
- Is dental school becoming unattainable? 6 dentists weigh in
- Peak Dental Services becomes 1st DSO to deploy clinician well-being framework
- Aspen Dental continues expansion with South Carolina practice
- Texas safety net behavioral health provider projects $15M shortfall
- 4 dental deals totaling $308M
- Huahai poaches quality chief from Hengrui amid FDA manufacturing citations
- 24 new behavioral health study findings to know
- Maryhaven CEO steps down amid financial concerns
- GE HealthCare, Catholic Health strike 10-year, $500M technology partnership
- Thriveworks launches insight dashboard for referring providers
- What’s driving Arizona’s drug death surge? 6 things to know
- CMS proposal to block third-party vendors will upend remote monitoring services, health tech leaders say
- FDA Clears First Cholesterol Pill, Lipfendra, To Rival Costly Injections
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- One Of The Largest Epidural Studies Ever Delivers Reassuring News For Parents
- Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US
- Coalition for Health AI launches implementation initiative for public health agencies
- Vanda shifts Nereus marketing into high gear with Schumacher IndyCar sponsorship
- Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?
- Heatwaves During Pregnancy Could Affect Baby's Brain Development, Study Suggests
- Brain 'Microstimulation' Works Long-Term To Restore Sense Of Touch After Spinal Cord Injury
- Otters, bears and Pharma Lions: inside Gilead’s bronze-winning Cannes spot
- 'Night Owls' At Risk Of Wider Waistlines, Unhealthy Hearts
- Facing Funding Losses, States Call Out Big Businesses With Employees On Medicaid
- Listen to the Latest ‘KFF Health News Minute’
- A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry
- Readers Share Personal Insights on Deadly Denials and Pregnancy Centers
- Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment
- UnitedHealth Group to maintain 'restless' even after topping investor's Q2 expectations, CEO says
- 6 weeks into California’s psychiatric staffing mandate: What hospital leaders should know
- The best opportunities to expand behavioral healthcare access
- PsychPlus acquires Koa Health to scale mental health platform
- Senate HELP committee grills CDC nominee Erica Schwartz on vaccine policy, resistance to political interference
- 2 states join in expanding psychologist prescribing authority
- Ohio behavioral health clinic owners indicted in $9.3M Medicaid fraud case
- Bipartisan House bill tying doc pay to inflation earns resounding applause from providers
- West Tennessee Healthcare expands critical care support through eICU Program in partnership with Philips and hellocare.ai
- Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
- Novo gains head start on Lilly with European Commission approval of Wegovy pill
- Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first
- Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
- Lark Health, Samsung team up on AI-powered health coach for U.S. seniors
- 340B drug purchases hit at least $100B in 2025, administrator reports
- Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too
- No patent protection for Stelara? No problem for J&J as Tremfya fills the void
- Amazon Pharmacy partners with eNavvi to provide real-time medication pricing, delivery info to providers
- Are Microplastics Linked To Higher Heart Attack Risk?
- Impulsivity In Third Grade Could Point To Future Struggles
- AI Can Create 'Ghosts' Of Lost Loved Ones, But Would You Want To Meet Them?
- Blood Test May Predict Alzheimer's Risk Up To 10 Years Before Symptoms Begin
- Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
- OpenAI’s health AI chief: ‘Bet on the models getting better’
- Knee Pain? Ragged Cartilage? Research Suggests Surgery's Not The Best Answer
- THC/CBD Combo Might Ease Agitation In Late-Stage Dementia
- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Full-body scan startup Neko Health scores $700M to break into the U.S. market
- Elevance Health leaves D.C. Medicaid market, mulls future exits
- Sanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
- Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Judi Health rebrands PBM arm as Judi Rx, unveils Judi Care unit
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- Anthropic bets bigger on healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Remarks before the American-Hellenic Chamber of Commerce
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
- Regulatory tracker: Eisai, Biogen scoop up subQ Leqembi starter dose nod
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
Michigan healthcare freedom community forum
Think the author of this post has the entities suing the Federal government wrong. It is the Dayton Chamber of Commerce suing, with the backing of the U.S. Chamber of Commerce:
US Chamber of Commerce sues over government's drug pricing power
By Jonathan Stempel - June 9, 2023June 9 (Reuters) - The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical companies.
In a complaint filed in federal court in Dayton, Ohio, the chamber said the pricing program violated drugmakers' due process rights under the U.S. Constitution by giving the government "unfettered discretion" to dictate maximum prices.
It also said the program would impose exorbitant penalties on drugmakers that don't accept those prices, and amounted to an ultimatum: "agree to whatever price the government names, or we'll smash up your business."
The U.S. Department of Health and Human Services administers Medicare through its Centers for Medicare & Medicaid Services.
A spokeswoman said the agency will vigorously defend the program, which is already helping lower healthcare costs for older adults and people with disabilities. "The law is on our side," she added.
Friday's lawsuit by the chamber, one of the most powerful U.S. business groups, came three days after Merck & Co (MRK.N) filed a similar lawsuit in Washington, D.C.
Both lawsuits contended that price controls would force drugmakers to pull back on developing new drugs, causing long-term harm to Americans and their health.
Other drugmakers have also objected to the pricing program, which is part of last year's Inflation Reduction Act. Pricing changes following negotiations on 10 costly drugs selected by CMS would take effect in 2026.
Americans pay more for prescription drugs than prices in any other country.
The Biden administration hopes to save $25 billion annually by 2031 by having Medicare, the government health plan for people 65 and over, negotiate prices.
White House spokeswoman Karine Jean-Pierre said on Tuesday the government was confident it would win the Merck case.
"There is nothing in the Constitution that prevents Medicare from negotiating lower drug prices," she said.
The chamber also warned that allowing the pricing program would set a bad precedent.
"After all, if the government can impose price controls in the pharmaceutical industry, why not elsewhere?" Chief Policy Officer Neil Bradley said in a statement.
The case is Dayton Area Chamber of Commerce et al v Becerra et al, U.S. District Court, Southern District of Ohio, No. 23-00156.
Now up to 4 Pharma/Chamber of Commerse lawsuits contesting Medicare drug price negotiation.
Pharmaceutical trade group sues US over Medicare drug price negotiation plans
NEW YORK, June 21 (Reuters) - The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading industry lobby group, and two other organizations on Wednesday said they were suing the U.S. government to block enforcement of a program that gives Medicare the power to negotiate drug prices.
In a complaint filed in a federal court in Texas, PhRMA along with the National Infusion Center Association and the Global Colon Cancer Association, which counts PhRMA and some drug companies as members, said the drug price negotiation program was unconstitutional.
This marks the fourth lawsuit challenging the law, which is part of President Joe Biden’s signature Inflation Reduction Act (IRA), after separate legal challenges by Merck & Co (MRK.N), Bristol Myers Squibb (BMY.N), and the influential business group the U.S. Chamber of Commerce.
The pharmaceutical industry claims negotiating prices of its products with the government health plan for Americans age 65 and older will curtail profits and compel them to pull back on developing groundbreaking new treatments.
PhRMA represents many of the largest pharmaceutical companies in the world, including Merck and Bristol Myers.
Americans pay more for prescription medicines than any other country. The Biden administration's drug pricing reform aims to save $25 billion annually by 2031 through price negotiations for the drugs most costly to Medicare.
The latest lawsuit argues that the "unrestrained authority" given to the Department for Health and Human Services (HHS) by Congress conflicts with the United States' separation-of-power principle.
"Congress took a series of unconstitutional shortcuts, giving the executive branch the open ended task of replacing market based prices in Medicare with an entirely new set of prices at the (Medicare) agency's own choosing," PhRMA general counsel James Stansel said at a press conference.
The lawsuit also contends that the price negotiation program violates the U.S. Constitution's Eight Amendment, which protects against excessive fines, and Fifth Amendment by exempting key decisions from public input.
PhRMA and the other two groups are seeking an injunction against the price caps and a declaration that the IRA's price negotiation is unconstitutional.
The negotiations are scheduled to start in September after the agency that runs Medicare and Medicaid releases its list of 10 costly drugs initially selected for the process, with the agreed prices taking effect in 2026.
The suits challenging the plan have been filed in four different federal courts, with Merck's in Washington, D.C., the Chamber of Commerce in Ohio and Bristol Myers' in New Jersey.
In response to the previous lawsuits, the White House said there is nothing in the U.S. Constitution that prevents Medicare from negotiating lower drug prices.
A spokesperson for HHS on Wednesday said the law is on its side.
“As the (HHS) secretary has already made clear, we will vigorously defend the president’s drug price negotiation law, which is already helping to lower healthcare costs for seniors and people with disabilities."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
